These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2137384)
21. The synergistic immunosuppressive potential of cyclosporin metabolite combinations. Radeke HH; Christians U; Sewing KF; Resch K Int J Immunopharmacol; 1992 May; 14(4):595-604. PubMed ID: 1521927 [TBL] [Abstract][Full Text] [Related]
22. A preliminary study to evaluate an in vitro assay for determining patient whole blood immunosuppressive cyclosporine A and metabolite activity: comparison with cytosolic binding assays using cyclophilin or a 50-kilodalton binding protein, and the Abbott TDx cyclosporine A parent, and parent and metabolites assays. Russell RL; Donnelly JG; Palaszynski EW; Chan MM; Soldin SJ Ther Drug Monit; 1991 Jan; 13(1):32-6. PubMed ID: 1829283 [TBL] [Abstract][Full Text] [Related]
23. 15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity. Lhöest GJ; Maton N; Latinne D; Laurent A; Verbeeck RK Clin Chem; 1994 May; 40(5):740-4. PubMed ID: 7513627 [TBL] [Abstract][Full Text] [Related]
24. Cyclosporine's dual mechanism of action in inhibiting generation of the cytoplasmic activation signal and the nuclear response thereto. Citterio F; Kahan BD Transplantation; 1991 Jun; 51(6):1248-57. PubMed ID: 1904664 [TBL] [Abstract][Full Text] [Related]
25. The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells. Eiras G; Hashem H; Zeevi A; Wong L; Duquesnoy RJ; Burckart GJ J Clin Pharmacol; 1991 Jan; 31(1):72-5. PubMed ID: 2045531 [TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of cyclosporine A and its three metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients. Brozmanová H; Perinová I; Halvová P; Grundmann M J Sep Sci; 2010 Aug; 33(15):2287-93. PubMed ID: 20589784 [TBL] [Abstract][Full Text] [Related]
27. Mass spectrometric analysis of cyclosporine metabolites. Hartman NR; Jardine I Biomed Environ Mass Spectrom; 1986 Jul; 13(7):362-72. PubMed ID: 2943349 [TBL] [Abstract][Full Text] [Related]
28. Excretion of cyclosporine and its metabolites in human bile. Burckart GJ; Starzl TE; Venkataramanan R; Hashim H; Wong L; Wang P; Makowka L; Zeevi A; Ptachcinski RJ; Knapp JE Transplant Proc; 1986 Dec; 18(6 Suppl 5):46-9. PubMed ID: 3538573 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro. Rayat G; Yatscoff R; Silverman R; McKenna R Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression. Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033 [TBL] [Abstract][Full Text] [Related]
31. Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations. Christians U; Radeke HH; Kownatzki R; Schiebel HM; Schottmann R; Sewing KF Clin Biochem; 1991 Jun; 24(3):271-5. PubMed ID: 1714802 [TBL] [Abstract][Full Text] [Related]
32. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters. Vollenbroeker B; Koch JH; Fobker M; Suwelack B; Hohage H; Müller U Transplant Proc; 2005 May; 37(4):1741-4. PubMed ID: 15919451 [TBL] [Abstract][Full Text] [Related]
33. Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells. Radeke HH; Christians U; Bleck JS; Sewing KF; Resch K Kidney Int; 1991 Jun; 39(6):1255-66. PubMed ID: 1895678 [TBL] [Abstract][Full Text] [Related]
34. In vitro immunosuppressive properties of cyclosporine metabolites. Freed BM; Rosano TG; Lempert N Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307 [TBL] [Abstract][Full Text] [Related]
35. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482 [TBL] [Abstract][Full Text] [Related]
36. Isolation and structural identification of 9hydroxy-9desmethyl-cyclosporine. Bowers LD; Norman DD; Yan XX; Scheeler D; Carlson KL Clin Chem; 1990 Nov; 36(11):1875-9. PubMed ID: 2242562 [TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatographic column-switching method for two cyclosporine metabolites in blood. Gmur DJ; Meier P; Yee GC J Chromatogr; 1988 Mar; 425(2):343-52. PubMed ID: 3286668 [TBL] [Abstract][Full Text] [Related]
38. Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunction. Schlitt HJ; Christians U; Bleck J; Kohlhaw K; Ringe B; Bunzendahl H; Sewing KF; Wonigeit K; Pichlmayr R Transpl Int; 1991 Apr; 4(1):38-44. PubMed ID: 1829359 [TBL] [Abstract][Full Text] [Related]